RadioPharm Theranostics reaches 50% enrollment in Phase 2b RAD101 study for imaging brain metastases
Proactive - Interviews for investors · Proactive Investors
November 18, 20255m 16s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.